{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:00:49Z","timestamp":1789513249687,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bioorg.2020.104399","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T22:28:26Z","timestamp":1603232906000},"page":"104399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors"],"prefix":"10.1016","volume":"105","author":[{"given":"Khaled","family":"El-Adl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Ghany A.","family":"El-Helby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmy","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Elwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104399_b0005","series-title":"DNA binders and related subjects","first-page":"55","article-title":"Cyanine dye\u2013DNA interactions: intercalation, groove binding, and aggregation","author":"Armitage","year":"2005"},{"issue":"5","key":"10.1016\/j.bioorg.2020.104399_b0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem. Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2020.104399_b0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrc2607","article-title":"Targeting DNA topoisomerase II in cancer chemotherapy","volume":"9","author":"Nitiss","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"1-2","key":"10.1016\/j.bioorg.2020.104399_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mrfmmm.2007.03.008","article-title":"Noncovalent interactions with DNA: an overview","volume":"623","author":"Strekowski","year":"2007","journal-title":"Mutation Res."},{"key":"10.1016\/j.bioorg.2020.104399_b0025","first-page":"212","article-title":"Chemistry and biology of DNA-binding small molecules","volume":"102","author":"Paul","year":"2012","journal-title":"Curr. Sci."},{"key":"10.1016\/j.bioorg.2020.104399_b0030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12038-012-9212-8","article-title":"Structural studies on ligand\u2014DNA system. A rubst approach in drug design","volume":"37","author":"Kumar","year":"2012","journal-title":"J. of Biosci."},{"issue":"6","key":"10.1016\/j.bioorg.2020.104399_b0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.copbio.2007.09.006","article-title":"DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action","volume":"18","author":"Palchaudhuri","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bioorg.2020.104399_b0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-044452220-7\/50068-X","article-title":"WatsonCrick hydrogen bonds: nature and role in DNA replication","volume":"19","author":"Guerra","year":"2006","journal-title":"Modern Meth. Theor. Phys. Chem. Biopolym."},{"issue":"22","key":"10.1016\/j.bioorg.2020.104399_b0045","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1016\/j.bmcl.2015.10.024","article-title":"Watson\u2013Crick hydrogen bonding of unlocked nucleic acids","volume":"25","author":"Langkj\u00e6r","year":"2015","journal-title":"Bioorg. Medi. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104399_b0050","unstructured":"H. Lodish, et al., The Role of topoisomerases in DNA replication, Molecular Cell Biology, fourth ed., Section 12.3, 2000, Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK21703\/ (accessed April 2018)."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104399_b0055","first-page":"105","article-title":"Emerging DNA topoisomerase inhibitors as anticancer drugs","volume":"9","author":"Denny","year":"2004","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.bioorg.2020.104399_b0060","series-title":"Comprehensive Review for NCLEX-PN","author":"Hogan","year":"2012"},{"issue":"2","key":"10.1016\/j.bioorg.2020.104399_b0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BCJ20160583","article-title":"Topoisomerases as anticancer targets","volume":"475","author":"Delgado","year":"2018","journal-title":"Biochem J."},{"key":"10.1016\/j.bioorg.2020.104399_b0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/0929867053363414","article-title":"The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work","volume":"12","author":"Martinez","year":"2005","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104399_b0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev.bi.58.070189.002031","article-title":"DNA topoisomerase poisons as antitumor drugs","volume":"58","author":"Liu","year":"1989","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.bioorg.2020.104399_b0080","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bmc.2008.11.072","article-title":"Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity","volume":"17","author":"Chilin","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104399_b0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7326\/0003-4819-105-1-67","article-title":"Mitoxantrone: a new anticancer drug with significant clinical activity","volume":"105","author":"Shenkenberg","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bioorg.2020.104399_b0090","series-title":"Medicinal Chemistry of Anticancer Drugs","first-page":"199","article-title":"DNA Intercalators and topoisomerase inhibitors","author":"Avendano","year":"2008"},{"issue":"26","key":"10.1016\/j.bioorg.2020.104399_b0095","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1021\/bi00452a006","article-title":"Antitumor drug nogalamycin binds DNA in both grooves simultaneously: molecular structure of nogalamycin-DNA complex","volume":"28","author":"Liaw","year":"1989","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.bioorg.2020.104399_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900123","article-title":"Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors","volume":"352","author":"Eissa","year":"2019","journal-title":"Archiv der Pharmazie"},{"key":"10.1016\/j.bioorg.2020.104399_b0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejmech.2018.06.004","article-title":"Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors","volume":"155","author":"Ibrahim","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2020.104399_b0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1871520617666170710182405","article-title":"Design and discovery of novel quinoxaline derivatives as dual DNA intercalators and topoisomerase II inhibitors","volume":"18","author":"Eissa","year":"2018","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104399_b0115","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1002\/anie.201511881","article-title":"The benzyl moiety in a quinoxaline-based scaffold acts as a DNA intercalation switch","volume":"55","author":"Mahata","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2020.104399_b0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2018.04.056","article-title":"Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors","volume":"154","author":"Oyallon","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104399_b0125","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejmech.2017.11.067","article-title":"DNA intercalators based on (1, 10-phenanthrolin-2-yl) isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma","volume":"143","author":"Varrica","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104399_b0130","first-page":"9","article-title":"Molecular and cellular toxicological profiling of DNA bis-intercalator, quinoxaline compounds: echinomycin as the versatile lead","volume":"14","author":"Park","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"9","key":"10.1016\/j.bioorg.2020.104399_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000079","article-title":"5-(4-Methoxybenzylidene)thiazolidine-2,4-dione-derived VEGFR-2 inhibitors: design, synthesis, molecular docking, and anticancer evaluations","volume":"353","author":"El-Adl","year":"2020","journal-title":"Arch Pharm."},{"issue":"8","key":"10.1016\/j.bioorg.2020.104399_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000068","article-title":"Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2,4(1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors","volume":"353","author":"El-Adl","year":"2020","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.104399_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104059","article-title":"Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme","volume":"102","author":"El-Adl","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2020.104399_b0150","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900178","article-title":"Benzoxazole\/benzothiazole-derived VEGFR-2 inhibitors: design, synthesis, molecular docking, and anticancer evaluations","volume":"352","author":"El-Helby","year":"2019","journal-title":"Archiv der Pharmazie"},{"issue":"10","key":"10.1016\/j.bioorg.2020.104399_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900113","article-title":"Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitors","volume":"352","author":"El-Helby","year":"2019","journal-title":"Archiv der Pharmazie"},{"issue":"8","key":"10.1016\/j.bioorg.2020.104399_b0160","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2174\/1871520618666180412123833","article-title":"Design, synthesis, in vitro anti-cancer activity, ADMET profile and molecular docking of novel triazolo [3, 4-a] phthalazine derivatives targeting VEGFR-2 enzyme","volume":"18","author":"El-Helby","year":"2018","journal-title":"Anti-Cancer Agents Med. Chem. (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)"},{"issue":"12","key":"10.1016\/j.bioorg.2020.104399_b0165","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700240","article-title":"Design, synthesis, molecular docking, and anticancer activity of phthalazine derivatives as VEGFR-2 Inhibitors","volume":"350","author":"El-Helby","year":"2017","journal-title":"Archiv der Pharmazie"},{"key":"10.1016\/j.bioorg.2020.104399_b0170","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2174\/1385272003375978","article-title":"Intercalative binding of small molecules to nucleic acids","volume":"4","author":"Graves","year":"2000","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.104399_b0175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/meth.1998.0584","article-title":"Stacking interactions and intercalative DNA binding","volume":"14","author":"Gago","year":"1998","journal-title":"Methods"},{"key":"10.1016\/j.bioorg.2020.104399_b0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2020.104399_b0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1023\/A:1008018106064","article-title":"Structure\u2013affinity relationships for the binding of actinomycin D to DNA","volume":"11","author":"Gallego","year":"1997","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2020.104399_b0190","doi-asserted-by":"crossref","first-page":"11493","DOI":"10.1021\/bi00204a011","article-title":"Binding of actinomycin D to the T (G) nT motif of double-stranded DNA: determination of the guanine requirement in nonclassical, non-GpC binding sites","volume":"33","author":"Bailey","year":"1994","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bioorg.2020.104399_b0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/molecules23010048","article-title":"Design, synthesis and cytotoxic evaluation of novel chalcone derivatives bearing triazolo[4,3-a]-quinoxaline Moieties as potent anticancer agents with dual EGFR kinase and tubulin polymerization inhibitory effects","volume":"23","author":"Alswah","year":"2017","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bioorg.2020.104399_b0200","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1080\/00397911.2010.537802","article-title":"Synthesis and antimicrobial activity of some novel quinoxalines","volume":"42","author":"Soliman","year":"2012","journal-title":"Synthetic Commun: Int. J. Rapid Commun. Synthetic Org. Chem."},{"issue":"6041","key":"10.1016\/j.bioorg.2020.104399_b0205","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.1204117","article-title":"Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide","volume":"333","author":"Wu","year":"2011","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.bioorg.2020.104399_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142774","article-title":"Study of the differential activity of thrombin inhibitors using docking, QSAR, molecular dynamics, and MM-GBSA","volume":"10","author":"Mena-Ulecia","year":"2015","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2020.104399_b0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"17","key":"10.1016\/j.bioorg.2020.104399_b0220","first-page":"4827","article-title":"Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bioorg.2020.104399_b0225","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1128\/AEM.65.8.3727-3729.1999","article-title":"The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities","volume":"65","author":"Freimoser","year":"1999","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bioorg.2020.104399_b0230","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/np50089a004","article-title":"A colorimetric microassay for the detection of agents that interact with DNA","volume":"55","author":"Burres","year":"1992","journal-title":"J. Nat. Prod."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820316977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820316977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:10:06Z","timestamp":1758615006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820316977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":46,"alternative-id":["S0045206820316977"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104399","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104399"}}